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Introduction
There has been recent growth in the evidence for an association between depression and inflammation. Increased blood levels of inflammatory proteins (cytokines, like interleukin-6 (IL6), and C-reactive protein (CRP)) and increased expression of innate immune-related genes have been repeatedly reported in case-control studies of major depressive disorder (MDD) compared to non-depressed controls (1) (2) (3) (4) (5) (6) . There is experimental evidence that inflammation can cause depressive behaviours, both from animal studies showing that exposure to pro-inflammatory cytokines results in social withdrawal and anhedonia (7) , and from human studies demonstrating that treatment (for hepatitis) with a pro-inflammatory cytokine (interferon) is followed by increased incidence of MDD (8) . Convergently, meta-analytic reviews of clinical trial data have consistently demonstrated that anti-inflammatory drugs can significantly improve mood and fatigue symptoms, measured as secondary endpoints, in cases with major inflammatory disorder (9) (10) (11) .
Thus inflammatory mechanisms could be plausible targets for repurposing or de novo development of anti-inflammatory drugs for anti-depressant efficacy in cases with "inflamed depression", i.e., clinical symptoms of depression associated with clinical or biomarker evidence of inflammation. Inflamed depression hypothetically includes cases of "co-morbid" depression associated with major medical inflammatory disease; as well as a subgroup of MDD cases with low-grade inflammation detectable by blood or brain biomarkers. The concept of inflamed depression as a subgroup of MDD implies that there is an un-inflamed subgroup of cases who are depressed without any evidence for inflammation. This is an important distinction to be able to make in the design of clinical Lynall et al. Immune cell systems and subgroups of depression Revised submission to Biological Psychiatry, October 2019 5 trials for immunergic anti-depressant drugs, which should be precisely focused on the cases most likely to have a positive benefit:risk response to treatment.
Blood proteins -like cytokines and CRP -have been the focus of most immune biomarker research in psychiatry, to date; the potential utility of cellular immune markers has been relatively under-explored (12) (13) (14) (15) (16) (17) (18) . Most case-control studies of leucocyte subsets have used small samples, limited immunophenotyping panels, and have generated somewhat inconsistent results. Depression has been reproducibly associated with leucocytosis, increased neutrophil to lymphocyte ratio, and increased ratio of CD4 + to CD8 + T cells (19) (20) (21) . However, there are less consistent results concerning regulatory T cells, Th17 cells, natural killer (NK) cells, monocytes, and B cells (12-16, 18, 22) . Other psychiatric disorders, including schizophrenia, bipolar disorder and autism have also been associated with altered cell counts (23) (24) (25) . Notably, most prior studies have measured the relative frequency of each immune cell subset in proportion to the superset of peripheral blood mononuclear cells (PBMCs). Such relative cell counts are difficult to interpret since a decrease in the relative proportion of any given subset may reflect either an absolute decrease in their number or an absolute increase in the number of another PBMC subset.
We measured absolute numbers of 14 immune cell subsets from peripheral blood samples in 206 cases of depression and 77 healthy controls. We used multiple univariate and multivariate methods to identify cell counts that were significantly different between all cases and controls, and to explore the correlations between immune cells, inflammatory proteins and clinical variables. We tested the hypothesis Lynall 
et al. Immune cell systems and subgroups of depression
Revised submission to Biological Psychiatry, October 2019 6 that a subgroup of depressed cases would have peripheral inflammation (26, 27) by a "top-down" analysis, dividing the cases into two subgroups based on their immune cell profiles, then testing for significant differences between them in terms of inflammatory proteins and clinical variables. We also used a more "bottom-up" or data-driven analysis to identify a theoretically unconstrained number of immune cell-stratified subgroups of cases and then tested for immunological and clinical differences between subgroups.
Materials and Methods

Study design
This was a case-control study of peripheral blood cell counts in depression cases and healthy controls.
Depression cases were ascertained as those participants who screened positive for current or past depressive symptoms on the SCID screening questionnaire (28), completed the Hamilton Rating Scale for Depression (HAM-D), and screened negative for bipolar disorder or non-affective psychosis. 114 cases (55%) had moderate-severe depressive symptoms (HAM-D ≥ 17), of whom 61% were currently taking antidepressant medication; 50 cases (24%) had mild depressive symptoms (HAM-D 8-16) of whom 90% were currently medicated; and 42 cases (20%) had minimal depressive symptoms (HAM-D ≤ 7) of whom 100% were medicated. By design, this was a clinically heterogeneous sample inclusive of depressed cases across a spectrum of symptom severity and antidepressant medication exposure.
Matched healthy controls were recruited from the general population by advertisement and defined as participants with no personal history of depression, no previous antidepressant treatment for any indication, no history of any major psychiatric disorder as defined by SCID screening questionnaire, and by current HAM-D total score <7.
All participants satisfied inclusion criteria including age 25-50 years, and exclusion criteria including major medical disorder and immune-modulating drug treatment; see SI Methods for full list of eligibility criteria.
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Assessments
Participants completed the following clinical assessments and self-report questionnaires: Hamilton Depression Rating Scale (29); Beck Depression Inventory v2.0 (30); Chalder Fatigue Scale (31); Snaith-Hamilton Pleasure Scale (32); State-Trait Anxiety Inventory (33); Childhood Trauma Questionnaire (34); and Life Events Questionnaire (35). Height and weight were measured to calculate body mass index (mass / height 2 ). For 269 of the 283 participants, the HAM-D, CRP, absolute cell counts and flow cytometry were measured in the same month; and, for all participants, these assessments were completed within 80 days.
Fasting venous blood samples were taken between 8am and 10.30am for measurement of absolute blood cell counts (neutrophils, eosinophils, basophils, lymphocytes, monocytes, red cells and platelets); flow cytometry (CD4 + T cells, CD8 + T cells, B cells, classical monocytes, non-classical monocytes, intermediate monocytes, CD16 hi NK cells, CD56 hi NK cells and NKT cells); high-sensitivity C-reactive protein; lipid profile; and plasma interleukin-6 (IL6). Flow cytometry was performed on fresh PBMCs using live-dead stain and antibodies against CD3, CD4, CD8, CD19, CD56, CD14 and CD16 (Table S1 ). Data were manually gated, blind to case/control status of each participant, according to the strategy in Figure S2 . Flow cytometry counts were recorded as percentages relative to larger cell subsets, then multiplied by the relevant absolute cell counts to calculate absolute cell counts used in this study. For example, the absolute count of classical monocytes was calculated as the proportion of total monocytes that were classical monocytes (measured by cytometry) multiplied by the absolute number of monocytes (from the absolute cell count). This allowed calculation of absolute cell counts for CD4 + Table S2 for all calculations).
Immuno-phenotyping
and CD8 + T cells; classical, intermediate and non-classical monocytes; CD16 hi and CD56 hi NK cells; NKT cells, and B cells (see
Statistical analysis
All analyses were performed in [R] version 3.5.1 (R Core Team, 2018): see Data availability for code. P-values were corrected for multiple comparisons using the Benjamini-Hochberg procedure to control the false discovery rate (FDR). Group or subgroup effects on continuous variables were tested using Wilcoxon-Mann-Whitney or Kruskal Wallis tests, with FDR-corrected Conover non-parametric tests for post-hoc comparisons. (Sub)group effects on categorical variables were tested by 2 tests with FDR-corrected 2 tests for post-hoc pairwise comparisons; see SI Methods for details.
We used multivariate methods to deal with the high-dimensional, correlated data available on each participant. Principal components analysis (PCA) was used to identify the major dimensions of variation and co-variation over all 14 immune cell counts, using data from all participants; partial least square discriminant analysis (PLS-DA) was used to identify the weighted function of immune cell counts most predictive of case/control status; partial least squares regression (PLS-R) was used to identify the weighted function of all 14 immune cell counts most strongly associated with multiple (four) clinical measures of depression severity within the cases, viz, HAM-D, BDI, Chalder Fatigue and SHAPS scores. For both PLS discriminant analysis and regression, Pvalues for the predictive ability of the models were estimated by permuting group labels or clinical score sets (5000 permutations). Significant weights were defined as those with an absolute bootstrapped Z-score >3 (24) .
We used Gaussian finite multivariate mixture modeling, and consensus clustering, to identify subgroups of cases (and healthy controls) that shared an immune cell profile in common with each other and in contrast to the immune cells profile of cases in other subgroups (36, 37); see SI Methods for details.
Results
Sample characteristics
Quality-controlled absolute counts of 14 cell types were available on a sample of 283 participants comprising 206 depressed cases (143 female, 66 male) and 77 healthy controls (52 female, 25 male). Case and control groups did not significantly differ in terms of mean age, sex, or current use of tobacco or cannabis. As expected, the cases were significantly more depressed, anxious and fatigued, and reported significantly more current stress, childhood trauma, alcohol use and unemployment, than controls ( Table 1) . By design, the cases were clinically heterogeneous, and enriched for moderate-severe depressive symptom scores despite current or past treatment with monoaminergic anti-depressant medication (Figure S1 ).
Case-control differences in peripheral blood cell counts and inflammatory proteins
We first estimated case-control differences in peripheral blood cell counts and 
Correlational and principal components analysis of cellular, protein and clinical variables
We estimated correlations between all immunological, clinical and demographic variables in the whole sample (N=283) (Figure 1B) . Immune cell counts and inflammatory protein concentrations were positively correlated with each other, as were questionnaire measures of symptom severity and stress. The strongest pair-wise correlations between cell counts and clinical variables were between neutrophil count and HAM-D score (Spearman's ρ = +0.27, FDR P = 0.00003), and neutrophil count and BDI score (ρ = +0.25, FDR P = 0.0002). The correlation matrix estimated from data on cases only (N=206) was very similar to the whole sample matrix (Figure S3 ).
We used principal component analysis to summarise the correlated data on 14 blood cell counts in terms of the first 2 principal components, which together accounted for 29% of the total variance-covariance. The first principal component (PC1; 19% total (co)variance) was a weighted average of all cell counts, most strongly weighted on myeloid cells (neutrophils, basophils and classical monocytes) and CD4 + T cells (Figure   2A ). The second principal component (PC2; 10% total (co)variance) was most strongly weighted on classical and non-classical monocytes and CD16 hi NK cells ( Figure S4A) .
Similar results were obtained when PCA was repeated for sex-specific subgroups of cases ( Figure S4) . 
Discriminant analysis of immune cell counts most predictive of case/control status
We used partial least squares (PLS) discriminant analysis (Figure 3A, S4E ) to find the weighted function of the 14 immune cell counts that most accurately discriminated between cases and controls. This discriminant function accounted for a small but significant proportion (6.3%) of the variability in diagnostic status (P = 0.002, permutation test). Absolute cell counts for CD4 + T cells, neutrophils and eosinophils were significantly weighted on the discriminant function, indicating that a combination of these cell counts was most predictive of case/control status.
Association of immune cell counts with severity of depression in cases
We used PLS regression to test the hypothesis that a weighted function of immune cell counts predicted variability of depressive symptom severity among the cases. We found that a single PLS-R component accounted for a small (7.3%) but significant proportion of the variance in depressive symptom scores measured on multiple clinical questionnaires (HAM-D, BDI, Chalder Fatigue and SHAPS) (P = 0.001, permutation test). The cell counts significantly weighted on the PLS-R component were neutrophils, NKT cells and B cells, indicating that a combination of these three cell counts was most strongly related to symptom severity, especially as self-reported by the BDI (Figure 3B) .
"Top-down" analysis of two subgroups of depressed cases
To make a binary partition of depressed cases into two subgroups based only on their immune cell count data, we used Gaussian finite multivariate mixture modeling under the constraint that the number of distributions in the mixture must be two. This analysis identified one subgroup of N=81 cases (39%) that had increased absolute counts of several immune cells (monocytes, granulocytes, CD16 hi NK cells, NKT cells, B cells, T cells and platelets) compared to a second subgroup of cases (N=125, 61%) ( Figure   4A ,B).
The subgroup of cases with increased immune cell counts also had significantly increased inflammatory protein concentrations (CRP, P = 0.03, standard effect size = 0.16; and IL6, P = 0.02, standard effect size 0.19; Figure 4C , Table S4 ), compared to the second subgroup with decreased immune cell counts, and hence it was referred to as the inflamed depression subgroup. Cases of inflamed depression had significantly higher severity of observer-rated depressive symptoms (HAM-D, P = 0.0002, effect size = 0.26) and self-reported depressive symptoms (BDI, P = 0.01, effect size = 0.18), compared to the uninflamed depression cases. Inflamed vs uninflamed cases had twice the rate of unemployment (33% vs.17%, P = 0.008), were slightly older (median age 38 years vs. 34 years, P = 0.01), and more likely to be smokers (19% vs. 7%, P = 0.01).
However, the two subgroups did not differ significantly on sex, study center, current antidepressant use, alcohol or cannabis use, reported recent infection or minor inflammatory disease, or BMI (Figure S5A,B , Table S4 ).
Sensitivity analysis of immune cell binarization of un/inflamed depression
To test the robustness of this key result -that binarization of all depression cases on cell counts identifies immunologically and clinically distinct subgroups of inflamed and uninflamed depression -we conducted two sensitivity analyses and a benchmarking study (detailed in Supplemental Material and summarized briefly here): (i) robustness to diagnostic eligibility criteria: we included only the subset of depression cases with a SCID diagnosis of major depressive disorder (MDD; N=139); (ii) robustness to potential confounds in case-control data: we used linear regression to mitigate the effects of age, sex, BMI, recent infection history and tobacco use before case-control analysis of residualised counts of the 14 immune cell subsets (Figures 4, S5, S6) . In both these sensitivity analyses, we replicated identification of a subgroup of inflamed cases with more severe depressive symptoms. The first principal component of the residual cell counts was very similar to PC1 for the absolute counts (Figure 4E, S5A Data-driven clustering identified a subgroup of controls (N=20) with very low cell counts and a subgroup with slightly higher cell counts (N=57) (Figure S8A) . The marginally more inflamed subgroup was associated with higher BMI, higher IL-6, and male gender;
but had significantly lower lymphoid and myeloid counts than the inflamed MDD cluster ( Figure S8B) . (Figure 5B, S7A) . This four-way, bottom-up stratification of cases was not simply nested within the top-down binarization ( Table S6 ). There were no significant differences between these 4 immune cell-stratified subgroups in terms of multiple, potentially confounding demographic and clinical factors (Figure S7B , Table   S5 ).
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Discussion
Immune cell systems and depression
We confirmed case-control mean differences in CRP and IL6, as well as increased absolute counts of neutrophils, intermediate monocytes, and CD4 + T cells in depressed cases, by the conventional approach of multiple univariate testing ( Figure 1A) (1, 4, 5, 19) . We also observed that the immunological variables were correlated with each other, and with measures of depressive symptom severity, prompting further investigation with multivariate methods. The first principal component of the cellular data represented a weighted sum of all cell counts, especially myeloid and CD4 + T cells, and was positively correlated with both inflammatory protein concentrations and depressive symptom scores. Partial least squares (PLS) identified the weighted functions of immune cell counts, especially neutrophil cell counts, that optimally discriminated between cases or controls, or were most predictive of variation in depressive symptom severity.
These results, in the context of the prior literature, tell us that peripheral blood cell counts are plausible as candidate biomarkers of "inflamed depression", and the most informative cellular biomarkers are likely to summarise the status of a system of functionally or developmentally related cells, rather than a solitary "smoking gun".
Myeloid cells, especially neutrophils, were strongly implicated in these data. Absolute neutrophil numbers were increased in depressed cases, positively correlated with depressive symptom scores (Figure 1B) , and strongly weighted on the PLS functions that optimally discriminated cases from controls or predicted symptom severity (Figure   3 ). These findings are compatible with prior emphasis on the role of the innate immune system in depression and, more specifically, with reports of case-control differences in total leucocyte count, neutrophil count, or neutrophil/lymphocyte ratio (19) (20) (21) 38) . The hypercortisolemia observed in some depressed cases (39) may thus relate to the neutrophilia observed in these data and other studies (40, 41) . Neutrophils can traffic to the brain and neutrophil depletion has been shown to mitigate the effects of inflammation on behavior in animal models (42) .
However, it would be simplistic at this stage to assert that myeloid cells are the only immune cells relevant to depression. For example, CD4 + helper T cells were correlated with myeloid cell counts, increased in depressed cases, and strongly weighted on the PLS discriminant function. Helper T cells are known to facilitate cytokine production and other inflammatory responses by myeloid cells (43) ; and myeloid antigen presenting cells are important for activating and polarizing CD4 + T cells towards a terminally differentiated state (44) . In short, there are two-way interactions between myeloid and lymphoid cells that may underlie the observed pattern of depression-related change in multiple cell types. A role for adaptive as well as innate immunity in depression is also compatible with transcriptional results (6) that indicate coupled changes in peripheral whole blood expression of genes specialized for innate and adaptive immune functions.
Immune cell stratified subgroups of depression
These results also tell us that not all cases of depression are equally likely to be associated with abnormal immune cell counts, which is compatible with prior expectations of a subgroup of cases with "inflamed depression". We tested this prediction more explicitly using mixture modeling to decompose the multivariate distribution of immune cell counts in the depressed group into two or more component distributions or subgroups. Initially, we specified this analysis to identify two subgroups, which we found were indeed significantly different from each other immunologically and clinically. About 40% of depressed cases had increased immune cell counts, increased inflammatory proteins, and increased symptom severity scores, compared to the remaining 60% of uninflamed cases. These results are consistent with prior observations that approximately a third of MDD cases have CRP levels greater than the upper limit of the normal range (3 mg/L) and that depression is symptomatically more severe when associated with inflammation (4).
However, there is no prior reason to assume that there should be only one subgroup of inflamed depression. When the multivariate mixture analysis was repeated, without constraining the algorithm to find a binary solution, we found 4 immune cell-stratified subgroups, of which two were associated with equivalently-increased inflammatory proteins and depressive symptom scores compared to the uninflamed subgroup. These two inflamed subgroups together accounted for about two thirds of cases, suggesting that the proportion of depression cases associated with inflammation may be underestimated by the conventional cut-off of CRP > 3 mg/L. Intriguingly, the existence of two inflamed subgroups, differentiated by their distinctively myeloid-vs lymphoidbiased immune cell profiles, suggests that there may be more than one mechanistic pathway to the same syndrome of high depressive symptoms and increased inflammatory proteins. For example, some cases of inflamed depression may be caused primarily by proliferation or activation of myeloid cells, innately responding by pattern recognition receptors to acute stress or infection, whereas other cases may be driven by 
Methodological issues
Case-control designs are vulnerable to the effects of uncontrolled confounding variables and there are many demographic, clinical, and lifestyle factors that could have effects on peripheral immune biomarkers. This sample of cases was designed to encompasses considerable clinical heterogeneity, which is useful for the within-group analysis, but is not epidemiologically representative. The sample is large (N=283; 206 cases), and the number of cell subsets counted is large (p=14), by comparison to prior immune cell studies of MDD; the order of magnitude difference between N and p is desirable for multivariate analysis. However, it will require an order of magnitude increase in sample size to fully explore and exploit the cellular resolution of contemporary immunophenotyping for stratification of inflamed depression.
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First Table   S3 for underlying data and effects sizes. Forced two-way mixture modelling identified two clustered immunophenotypes, uninflamed depression (UD, n=125 cases, grey) and inflamed depression (ID, n=81, red). Plot shows the PCA scores for each case on cellular PC1 and PC2 (Figure S5A) , T r a i t a n x i e t y
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